Published in Neurosci Lett on February 17, 1995
Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx (2004) 2.02
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J Neurol Neurosurg Psychiatry (1998) 1.83
Biomarkers of Alzheimer's disease. Neurobiol Dis (2008) 1.37
Both total and phosphorylated tau are increased in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 1.26
Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am J Pathol (2002) 1.22
The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease. Neurobiol Aging (2007) 1.07
Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease. PLoS One (2013) 0.92
The role of tau in Alzheimer's disease and related disorders. CNS Neurosci Ther (2010) 0.91
CSF tau and β-amyloid as biomarkers for mild cognitive impairment. Dialogues Clin Neurosci (2004) 0.79
Biomarkers for the Early Detection and Progression of Alzheimer's Disease. Neurotherapeutics (2016) 0.78
The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood. Spinal Cord (2016) 0.75
Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation. Neurobiol Dis (2017) 0.75
Requirement of an Escherichia coli 50 S ribosomal protein component for effective interaction of the ribosome with T and G factors and with guanosine triphosphate. J Biol Chem (1972) 14.68
Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci (2001) 6.32
A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell (1994) 4.35
A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining. Acta Neuropathol (1988) 4.10
Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest (1991) 3.70
Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell (1994) 3.66
Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet (1998) 3.38
Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med (1997) 3.35
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab (2001) 3.16
Calcium-dependent protein kinase: widespread occurrence in various tissues and phyla of the animal kingdom and comparison of effects of phospholipid, calmodulin, and trifluoperazine. Proc Natl Acad Sci U S A (1980) 3.08
An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol (1998) 3.04
THE ENZYMATIC SYNTHESIS OF RNA: NEAREST-NEIGHBOR BASE FREQUENCIES. Proc Natl Acad Sci U S A (1961) 2.93
Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development (1998) 2.92
Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci U S A (1996) 2.79
Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med (1991) 2.75
A possible mechanism for initiation of protein synthesis. Proc Natl Acad Sci U S A (1966) 2.73
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J (1993) 2.66
Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab (2000) 2.43
Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. J Biochem (1978) 2.26
Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol (1998) 2.25
Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren's syndrome. Lancet (2001) 2.10
The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J Biol Chem (1996) 2.06
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology (1992) 2.06
Ultrastructure of the neuropil threads in the Alzheimer brain: their dendritic origin and accumulation in the senile plaques. Acta Neuropathol (1990) 2.03
Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis. J Biochem (1978) 2.02
Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis (1998) 2.01
Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc Res Tech (2000) 2.00
Organization of the biosynthetic gene cluster for the polyketide anthelmintic macrolide avermectin in Streptomyces avermitilis. Proc Natl Acad Sci U S A (1999) 1.98
Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A (1999) 1.96
The Drosophila homolog of the immunoglobulin recombination signal-binding protein regulates peripheral nervous system development. Cell (1992) 1.96
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes (2001) 1.94
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem J (2000) 1.84
Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism (2004) 1.82
Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol (1988) 1.81
Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem Biophys Res Commun (1993) 1.80
Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab (1997) 1.76
A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J Biol Chem (1994) 1.75
Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am J Dis Child (1979) 1.71
Biochemical and immunological characterization of the DNA binding protein (RBP-J kappa) to mouse J kappa recombination signal sequence. J Biochem (1992) 1.69
Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest (2000) 1.68
Constitutive synthesis of activator protein 1 transcription factor after viral transformation of mouse fibroblasts. Proc Natl Acad Sci U S A (1988) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res (2001) 1.64
Senile degenerative brain lesions and dementia. J Am Geriatr Soc (1975) 1.63
Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care (1994) 1.62
New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett (1991) 1.60
Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem Biophys Res Commun (1994) 1.60
Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes (1995) 1.58
Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells. J Immunol (1983) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes (1999) 1.55
C-type natriuretic peptide (CNP) in rats and humans. Endocrinology (1991) 1.54
Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study. Mov Disord (1998) 1.54
Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med (1990) 1.53
Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. Am J Pathol (1989) 1.53
The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem (2001) 1.50
Studies on the mechanism of polypeptide chain termination in cell-free extracts of E. coli. Proc Natl Acad Sci U S A (1966) 1.47
Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma. Cancer (1999) 1.47
Two Japanese CADASIL families with a R141C mutation in the Notch3 gene. Intern Med (2001) 1.46
Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology (1993) 1.46
Treatment of subdural effusion with hydrocephalus after ruptured intracranial aneurysm clipping. Neurosurgery (1998) 1.45
Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet (1991) 1.45
MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappaB activation and degradation of IkappaB-alpha. J Biol Chem (1996) 1.45
Pancreatic ductal adenocarcinoma associated with Potter type III cystic disease. J Gastroenterol (2001) 1.44
Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. J Neurosci Res (1996) 1.43
Drug-associated cholelithiasis: a case of sulindac stone formation and the incorporation of sulindac metabolites into the gallstones. Am J Gastroenterol (1999) 1.42
Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Biochem Biophys Res Commun (2000) 1.42
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology (2003) 1.42
Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Am J Pathol (1999) 1.41
Improvement of SSPE by intrathecal infusion of alpha-IFN. Neurology (2004) 1.40
Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies. J Immunol (1985) 1.40
Expression of phosphotyrosine and SNAP-25 immunoreactivity in grumose (foamy) spheroid bodies suggests axonal regeneration. Acta Neuropathol (1998) 1.39
Complication of adenoid cystic carcinoma and sialolithiasis in the submandibular gland: report of a case and its etiological background. Int J Oral Maxillofac Surg (2010) 1.39
Psoas abscess and cellulitis of the right gluteal region resulting from carcinoma of the cecum. J Gastroenterol (2001) 1.38
Gestational protein-energy malnutrition affects the composition of developing skins of rat fetuses and their dams. Br J Nutr (1987) 1.38
Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest (1993) 1.38
Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes (2001) 1.37
Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer (1994) 1.36
Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. J Neurochem (1997) 1.35
Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A (1996) 1.35
Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathol (1989) 1.35
Granular cell tumor of the urinary bladder. Int J Urol (2001) 1.32
Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am J Cardiol (2001) 1.32
The human endothelin-B receptor gene. Structural organization and chromosomal assignment. J Biol Chem (1993) 1.32
Rapid wall relaxation in elongating tissues. Plant Physiol (1988) 1.31
Spontaneous haemothorax associated with von Recklinghausen's disease: review of occurrence in Japan. Thorax (1997) 1.31
Application of live attenuated measles and mumps vaccines in children with acute leukemia. Biken J (1981) 1.30
Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. J Neurol (1992) 1.29